Shaily Engineering Plastics Limited (SEPL), a leading manufacturer of precision plastic components, has been honored with the prestigious Best Exporter Award for Engineering Components of Plastics for FY2023-24 and FY2024-25 by The Plastics Export Promotion Council (Plexcouncil). This recognition underscores SEPL's dominance in the export of engineering plastic components among Indian manufacturers.

Award Details and Significance

The award certificate, presented by Plexcouncil, acknowledges SEPL's outstanding performance in exporting the highest number of engineering plastic components among Indian plastic manufacturers. This achievement highlights the company's commitment to quality and its strong position in the global market for precision plastic components.

Company's Response

In an official communication to the stock exchanges, SEPL expressed its honor in receiving this recognition. The company stated, "This remarkable success is a testament to Company's dedication, and strategic vision." This award not only validates SEPL's export-oriented business model but also reinforces its reputation as a key player in the global plastic engineering sector.

Impact on Business and Future Outlook

While specific financial implications of this recognition were not disclosed, such awards typically boost a company's credibility in international markets. For SEPL, this accolade could potentially lead to:

• Enhanced brand reputation in global markets
• Increased interest from international clients
• Potential for securing more export orders

Investor Perspective

For investors, this award serves as a positive indicator of SEPL's competitive edge in the international market. It demonstrates the company's ability to meet global quality standards and compete effectively against other manufacturers worldwide.

Conclusion

The Best Exporter Award is a significant milestone for Shaily Engineering Plastics Limited, reflecting its excellence in manufacturing and exporting engineering plastic components. As the company continues to strengthen its position in the global market, stakeholders will be keen to observe how this recognition translates into tangible business growth and market expansion opportunities in the coming years.

Promoter Amit Mahendra Sanghvi has recently reduced his stake in Shaily Engineering Plastics Limited , a move that has caught the attention of market observers. The transaction, which took place on November 4, 2025, involved the disposal of 1,00,000 shares, representing 0.22% of the company's total share capital.

Impact on Shareholding

The share disposal has resulted in a decrease in Sanghvi's holding from 2.84% to 2.62% of the company's total share capital. This reduction, while modest, may be of interest to investors and market analysts tracking the company's ownership structure.

Transaction Details

Company Performance Context

While the share disposal is noteworthy, it's important to consider it in the context of Shaily Engineering Plastics Limited's recent performance. The company has been making strides in various segments, particularly in healthcare, where it has seen significant growth.

In the most recent quarter (Q2 FY26), Shaily Engineering Plastics reported:

• A revenue growth of 34% year-on-year, reaching INR 257.00 crores
• An EBITDA margin expansion of over 1,000 basis points to 31.80%
• A growth of 163% in the Healthcare segment, contributing to 38% of the overall revenue mix

Market Implications

The share disposal by a promoter can sometimes be interpreted in various ways by the market. However, it's crucial to note that such transactions may occur for various reasons, including personal financial planning, and may not necessarily reflect the promoter's view on the company's future prospects.

Given Shaily Engineering Plastics' performance and growth trajectory, especially in the healthcare segment, investors may want to closely monitor the company's future announcements and financial results to gain a more comprehensive understanding of its market position and growth potential.

As the company continues to expand its presence in key markets and develop innovative products like the recently launched Axiom Max pen for GLP-1 therapies, it will be interesting to see how this share disposal fits into the broader picture of the company's evolution and market strategy.